A systematic review of the international prevalence of BRCA mutation in breast cancer
N Armstrong, S Ryder, C Forbes, J Ross… - Clinical …, 2019 - Taylor & Francis
A systematic review was conducted, summarizing international BRCA 1 or 2 (BRCA1/2)
mutation prevalence in breast cancer. Databases (eg, Medline and Embase; N= 7) and …
mutation prevalence in breast cancer. Databases (eg, Medline and Embase; N= 7) and …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the US Preventive Services Task Force …
HD Nelson, M Pappas, B Zakher… - Annals of internal …, 2014 - acpjournals.org
Background: Mutations in breast cancer susceptibility genes (BRCA1 and BRCA2) are
associated with increased risks for breast, ovarian, and other types of cancer. Purpose: To …
associated with increased risks for breast, ovarian, and other types of cancer. Purpose: To …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement
DK Owens, KW Davidson, AH Krist, MJ Barry… - Jama, 2019 - jamanetwork.com
Importance Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes
(BRCA1/2) are associated with increased risk for breast, ovarian, fallopian tube, and …
(BRCA1/2) are associated with increased risk for breast, ovarian, fallopian tube, and …
Nationwide trends in mastectomy for early-stage breast cancer
Importance Accredited breast centers in the United States are measured on performance of
breast conservation surgery (BCS) in the majority of women with early-stage breast cancer …
breast conservation surgery (BCS) in the majority of women with early-stage breast cancer …
Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors
D Cragun, A Weidner, C Lewis, D Bonner, J Kim… - Cancer, 2017 - Wiley Online Library
BACKGROUND Breast cancer (BC) disparities may widen with genomic advances. The
authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) …
authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) …
[HTML][HTML] Diretrizes para detecção precoce do câncer de mama no Brasil. II-Novas recomendações nacionais, principais evidências e controvérsias
A Migowski, GA Silva, MBK Dias… - Cadernos de Saúde …, 2018 - SciELO Public Health
O câncer de mama é a principal causa de morte por câncer em mulheres no Brasil. As
novas diretrizes para detecção precoce no Brasil foram elaboradas com base em revisões …
novas diretrizes para detecção precoce no Brasil foram elaboradas com base em revisões …
Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women
R Manchanda, S Patel, VS Gordeev… - JNCI: Journal of the …, 2018 - academic.oup.com
Background The cost-effectiveness of population-based panel testing for high-and moderate-
penetrance ovarian cancer (OC)/breast cancer (BC) gene mutations is unknown. We …
penetrance ovarian cancer (OC)/breast cancer (BC) gene mutations is unknown. We …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US Preventive Services Task Force recommendation statement
VA Moyer… - Annals of internal …, 2014 - acpjournals.org
Description: Update of the 2005 US Preventive Services Task Force (USPSTF)
recommendation on genetic risk assessment and BRCA mutation testing for breast and …
recommendation on genetic risk assessment and BRCA mutation testing for breast and …
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive …
Importance Pathogenic mutations in breast cancer susceptibility
genesBRCA1andBRCA2increase risks for breast, ovarian, fallopian tube, and peritoneal …
genesBRCA1andBRCA2increase risks for breast, ovarian, fallopian tube, and peritoneal …
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history–based testing
R Manchanda, R Legood, M Burnell… - Journal of the …, 2015 - academic.oup.com
Background: Population-based testing for BRCA1/2 mutations detects the high proportion of
carriers not identified by cancer family history (FH)–based testing. We compared the cost …
carriers not identified by cancer family history (FH)–based testing. We compared the cost …